Aktuelles

Bilder

10 examples
Testbiotech shows increasing number of patents on food plants and New GE
Project Genetic Engineering and the Environment // Background Information Videos
Gene Drive - intervention in the "germline" of natural diversity
previous pauseresume next

New findings on the evolution of plants

Research outcomes also concern the differences between New GE and conventional breeding

14 January 2022 / A new scientific publication in Nature shows that the occurrence of mutations in plant genomes is not purely random, and their frequencies in populations do not only depend on the mechanisms of selection. However, it is now becoming evident that there are natural mechanisms in the genome which prevent specific genomic regions from frequent mutations. The published research sheds new light on evolutionary biology and, at the same time, raises questions in regard to the consequences of genetic engineering in plants.

EU Commission ignores scientific findings on New GE risks

CRISPR/Cas techniques create new hazards

21 December 2021 / Testbiotech has received a letter from the EU Commission setting out its views in relation to new publications on the risks associated with CRISPR/Cas genetic scissors. In their opinion, any hazard potential arising from unintended genetic changes caused by the processes of New GE, is no different to that of conventional breeding. Existing scientific evidence, however, contradicts this view.

Uncontrolled spread of GE oilseed rape: a global problem

Concern in EU Member states

17 December 2021 / A recent Korean publication shows that the uncontrolled spread of genetically engineered (GE) oilseed rape is already happening in 14 countries on five continents. These are countries which either allow the cultivation of GE oilseed rape (such as the USA and Canada), or have tested it in experimental releases (such as Germany), or allow the import of kernels (such as Japan). Moreover, it has to be assumed that there is a high number of undetected cases, as many regions do not have systematic monitoring.

CRISPR patent hanging in the balance

After opposition by Testbiotech: ethical boundaries could be strengthened

3 December 2021 / The European Patent Office (EPO) held discussions on a CRISPR/Cas patent (EP 3401400) from 29 November until 1 December without coming to a final decision. The Nobel Prize laureates, Jennifer Doudna and Emmanuelle Charpentier, are named among the inventors of the patent.

Pages

Alle | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009